Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJ NYSE:JPM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$174.96+0.3%$160.85$140.68▼$175.72$420.06B0.418.58 million shs8.24 million shsJPMJPMorgan Chase & Co.$294.03+1.2%$285.93$200.61▼$301.29$798.89B1.118.05 million shs6.32 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+0.39%+2.07%+12.60%+15.59%+10.41%JPMJPMorgan Chase & Co.+1.22%+2.44%+2.67%+9.86%+39.96%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJNJJohnson & Johnson4.8448 of 5 stars2.35.04.23.93.61.71.9JPMJPMorgan Chase & Co.4.804 of 5 stars2.34.04.22.03.92.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.65Moderate Buy$174.50-0.26% DownsideJPMJPMorgan Chase & Co. 2.52Moderate Buy$288.68-1.82% DownsideCurrent Analyst Ratings BreakdownLatest JNJ and JPM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/23/2025JNJJohnson & JohnsonErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy7/17/2025JNJJohnson & JohnsonPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight7/17/2025JNJJohnson & JohnsonBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$165.00 ➝ $176.007/17/2025JNJJohnson & JohnsonRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$181.00 ➝ $185.007/17/2025JNJJohnson & JohnsonUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$180.00 ➝ $190.007/17/2025JNJJohnson & JohnsonGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$164.00 ➝ $167.007/17/2025JNJJohnson & JohnsonBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$161.00 ➝ $175.007/17/2025JNJJohnson & JohnsonMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$171.00 ➝ $176.007/16/2025JPMJPMorgan Chase & Co.CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy7/16/2025JPMJPMorgan Chase & Co.Phillip SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeModerate Buy ➝ Hold7/16/2025JPMJPMorgan Chase & Co.Wells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$320.00 ➝ $325.00(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$88.82B4.74$13.16 per share13.29$32.58 per share5.37JPMJPMorgan Chase & Co.$278.91B2.90$22.28 per share13.20$122.51 per share2.40Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$9.3518.7115.812.2225.00%32.49%13.00%10/21/2025 (Estimated)JPMJPMorgan Chase & Co.$58.47B$19.4915.0915.141.9320.52%16.93%1.30%10/10/2025 (Estimated)Latest JNJ and JPM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/16/2025Q2 2025JNJJohnson & Johnson$2.68$2.77+$0.09$2.29$22.85 billion$23.74 billion7/15/2025Q2 2025JPMJPMorgan Chase & Co.$4.48$4.96+$0.48$5.24$43.76 billion$44.91 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.202.97%N/A55.61%64 YearsJPMJPMorgan Chase & Co.$5.601.90%N/A28.73%15 YearsLatest JNJ and JPM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/16/2025JNJJohnson & Johnsonquarterly$1.303.35%8/26/20258/26/20259/9/20255/19/2025JPMJPMorgan Chase & Co.quarterly$1.402.12%7/3/20257/3/20257/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.501.010.76JPMJPMorgan Chase & Co.1.250.880.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%JPMJPMorgan Chase & Co.71.55%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%JPMJPMorgan Chase & Co.0.47%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,1002.41 billion2.40 billionOptionableJPMJPMorgan Chase & Co.317,2332.75 billion2.74 billionOptionableJNJ and JPM HeadlinesRecent News About These CompaniesJPMorgan Chase & Co. Ceases Substantial Holding in Silex Systems5 hours ago | msn.comPulteGroup (PHM) Extends Master Repurchase Agreement with JPMorgan ChaseAugust 14 at 10:09 PM | gurufocus.comWhy JPMorgan Is Sticking With Micron (MU) Stock for the Long HaulAugust 14 at 7:28 PM | insidermonkey.comPulteGroup Extends Mortgage Agreement with JPMorgan ChaseAugust 14 at 4:39 PM | tipranks.com$1 Billion Power Play: RXR and Liberty Just Made Their Boldest Bet Yet on U.S. ApartmentsAugust 14 at 4:14 PM | gurufocus.comNorth American Banks Lead Return to Office Compared to European CounterpartsAugust 14 at 2:27 PM | gurufocus.comJPMorgan Loses Two Credit Traders, Sales Head in Hong KongAugust 14 at 12:54 PM | bloomberg.comJP Morgan Raises Price Target for IHS (IHS) to $8.00, Maintains Overweight Rating | IHS Stock NewsAugust 14 at 12:35 PM | gurufocus.comLITE Stock Sees Raised Price Target by JP Morgan | LITE Stock NewsAugust 14 at 12:35 PM | gurufocus.comJP Morgan Raises Price Target for TIGO, Maintains Overweight Rating | TIGO Stock NewsAugust 14 at 12:35 PM | gurufocus.comJP Morgan Raises Price Target for Olema Pharmaceuticals (OLMA) to $29 | OLMA Stock NewsAugust 14 at 12:35 PM | gurufocus.comJP Morgan Raises Price Target for PAYX to $153, Maintains Underweight Rating | PAYX Stock NewsAugust 14 at 12:35 PM | gurufocus.comJP Morgan Maintains Neutral Rating, Raises Price Target for PNNT | PNNT Stock NewsAugust 14 at 12:35 PM | gurufocus.comCE Stock: JP Morgan Lowers Price Target to $40.00 | CE Stock NewsAugust 14 at 12:35 PM | gurufocus.comJP Morgan Lowers Price Target for ORIC Pharmaceuticals to $17 | ORIC Stock NewsAugust 14 at 12:35 PM | gurufocus.comSolid Biosciences (SLDB): JP Morgan Lowers Price Target to $13 | SLDB Stock NewsAugust 14 at 12:35 PM | gurufocus.comJP Morgan Lowers Westinghouse Air Brake (WAB) Price Target to $200 | WAB Stock NewsAugust 14 at 12:35 PM | gurufocus.comNIO (NIO): JP Morgan Raises Price Target, Maintains Neutral Rating | NIO Stock NewsAugust 14 at 12:35 PM | gurufocus.comWhy Is JPMorgan Chase & Co. (JPM) Up 1.7% Since Last Earnings Report?August 14 at 12:31 PM | zacks.comCapital Markets Bounce Back: What This Means for JPMorgan's ProspectsAugust 14 at 9:56 AM | zacks.comKing Luther Capital Management Corp Has $452.41 Million Position in JPMorgan Chase & Co. (NYSE:JPM)August 14 at 4:59 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025The Market Rally Is Gaining Momentum—Don’t Get Left BehindBy Thomas Hughes | July 17, 2025JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is NowBy Thomas Hughes | July 16, 2025Worried About a Fading Rally? Consider These 3 Dividend StocksBy Dan Schmidt | August 11, 2025JNJ and JPM Company DescriptionsJohnson & Johnson NYSE:JNJ$174.96 +0.54 (+0.31%) Closing price 08/14/2025 03:59 PM EasternExtended Trading$175.52 +0.56 (+0.32%) As of 08/14/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.JPMorgan Chase & Co. NYSE:JPM$294.03 +3.50 (+1.21%) Closing price 08/14/2025 03:59 PM EasternExtended Trading$294.40 +0.36 (+0.12%) As of 08/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Deere’s Sell-Off Could Be a Long-Term Buying Chance Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go? Mercury Systems Up 27%: Financials Send Investors a Clear Signal Brinker Serves Up Earnings Beat, Sidesteps Cost Pressures CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access